These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5157561)

  • 61. Selective toxicity of ochratoxin A in primary cultures from different brain regions.
    Belmadani A; Steyn PS; Tramu G; Betbeder AM; Baudrimont I; Creppy EE
    Arch Toxicol; 1999 Mar; 73(2):108-14. PubMed ID: 10350191
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Penicillium aurantiogriseum-induced, persistent renal histopathological changes in rats; an experimental model for Balkan endemic nephropathy competitive with ochratoxin A.
    Mantle PG; McHugh KM; Adatia R; Heaton JM; Gray T; Turner DR
    IARC Sci Publ; 1991; (115):119-27. PubMed ID: 1820324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carcinogenicity of sterigmatocystin to rat skin.
    Purchase IF; Van der Watt JJ
    Toxicol Appl Pharmacol; 1973 Oct; 26(2):274-81. PubMed ID: 4751106
    [No Abstract]   [Full Text] [Related]  

  • 64. THE CARCINOGENIC ACTION OF AFLATOXIN AFTER ITS SUBCUTANEOUS INJECTION IN THE RAT.
    DICKENS F; JONES HE
    Br J Cancer; 1963 Dec; 17(4):691-8. PubMed ID: 14111607
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of some mycotoxins on mitogen-induced blastogenesis and SCE frequency in human lymphocytes.
    Cooray R
    Food Chem Toxicol; 1984 Jul; 22(7):529-34. PubMed ID: 6235161
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
    Pfohl-Leszkowicz A; Manderville RA
    Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunochemical method for ochratoxin A.
    Usleber E; Dietrich R; Schneider E; Märtlbauer E
    Methods Mol Biol; 2001; 157():81-94. PubMed ID: 11050996
    [No Abstract]   [Full Text] [Related]  

  • 68. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity.
    Pfohl-Leszkowicz A; Manderville RA
    Chem Res Toxicol; 2012 Feb; 25(2):252-62. PubMed ID: 22054007
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and toxicology of 5,7-dibenzyloxycyclopentenone(2,3-c)coumarin. A model compound of aflatoxin B 1 .
    Wang CY; Parks PF
    J Med Chem; 1971 May; 14(5):447-8. PubMed ID: 5117693
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses.
    Wangikar PB; Dwivedi P; Sharma AK; Sinha N
    Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):352-8. PubMed ID: 15617025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. First synthesis of a stable isotope of Ochratoxin A metabolite for a reliable detoxification monitoring.
    Bouisseau A; Roland A; Reillon F; Schneider R; Cavelier F
    Org Lett; 2013 Aug; 15(15):3888-90. PubMed ID: 23883293
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mycotoxic diseases produced in mice by species of the Aspergillus ochraceus group.
    Zimmermann JL; Carlton WW; Tuite J; Fennell DI
    Food Cosmet Toxicol; 1977 Oct; 15(5):411-8. PubMed ID: 598791
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells.
    Schaaf GJ; Nijmeijer SM; Maas RF; Roestenberg P; de Groene EM; Fink-Gremmels J
    Biochim Biophys Acta; 2002 Nov; 1588(2):149-58. PubMed ID: 12385779
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aflatoxin and trichothecene toxins: skin tumor induction and synergistic acute toxicity in white mice.
    Lindenfelser LA; Lillehoj EB; Burmeister HR
    J Natl Cancer Inst; 1974 Jan; 52(1):113-6. PubMed ID: 4855757
    [No Abstract]   [Full Text] [Related]  

  • 75. Test for carcinogenicity of nifurtimox on oral and subcutaneous administration to rats.
    Steinhoff D; Grundmann E
    Arzneimittelforschung; 1972 Sep; 22(9):1607-12. PubMed ID: 4678719
    [No Abstract]   [Full Text] [Related]  

  • 76. Ochratoxin A--occurrence and toxicity.
    Munro C; Scott PM; Moodie CA; Willes RF
    J Am Vet Med Assoc; 1973 Dec; 163(11):1269-73. PubMed ID: 4586755
    [No Abstract]   [Full Text] [Related]  

  • 77. Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats.
    Maaroufi K; Zakhama A; Baudrimont I; Achour A; Abid S; Ellouz F; Dhouib S; Creppy EE; Bacha H
    Hum Exp Toxicol; 1999 Jun; 18(6):410-5. PubMed ID: 10413246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The toxicity and chemical assay of sterigmatocystin, a carcinogenic mycotoxin, and its isolation from two new fungal sources.
    Holzapfel CW; Purchase IF; Steyn PS; Gouws L
    S Afr Med J; 1966 Dec; 40(45):1100-1. PubMed ID: 6006093
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
    Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
    Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conversion of ochratoxin C into ochratoxin A in vivo.
    Fuchs R; Hult K; Peraica M; Radić B; Plestina R
    Appl Environ Microbiol; 1984 Jul; 48(1):41-2. PubMed ID: 6476830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.